Feasibility and oncologic outcome of en resection with intentional tumor transgression in primary spinal sarcoma: The Korean Society of Spinal Tumors multicenter study (KSST 2024–02)
Bong-Soon Chang , Se-Jun Park , Dong-Ho Kang , Jae Hwan Cho , Sehan Park , Sang-Il Kim , Young-Hoon Kim , Sang-Min Park , Sung-Kyu Kim , Chang-Bae Kong , Hyoungmin Kim , Sam Yeol Chang
{"title":"Feasibility and oncologic outcome of en resection with intentional tumor transgression in primary spinal sarcoma: The Korean Society of Spinal Tumors multicenter study (KSST 2024–02)","authors":"Bong-Soon Chang , Se-Jun Park , Dong-Ho Kang , Jae Hwan Cho , Sehan Park , Sang-Il Kim , Young-Hoon Kim , Sang-Min Park , Sung-Kyu Kim , Chang-Bae Kong , Hyoungmin Kim , Sam Yeol Chang","doi":"10.1016/j.jbo.2026.100747","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Primary spinal sarcoma is rare and technically challenging, particularly when attempting en bloc resection with negative margins. Intentional tumor transgression may be used when Enneking-appropriate en bloc resection is not feasible, but its oncologic implications remain unclear. This study evaluated the feasibility and outcomes of en bloc resection with intentional tumor transgression compared with other resection strategies.</div></div><div><h3>Methods</h3><div>This multicenter retrospective study included patients who underwent surgery for primary spinal sarcoma across five tertiary hospitals from 2000 to 2022. Patients were grouped by resection method: (A) en bloc resection with negative margins, (B) en bloc resection with intentional tumor transgression, (C) piecemeal resection, and (D) subtotal resection. Tumor extent was assessed using a modified Weinstein-Boriani-Biagini classification. The primary outcome was overall survival; secondary outcomes included local recurrence, distant metastasis, and perioperative complications.</div></div><div><h3>Results</h3><div>The study included 119 patients (mean age 46.0 ± 19.8 years). Oncological outcomes (overall survival, local recurrence, and distant metastasis) demonstrated significant trends in survival analysis across groups A to D. Although Group B had more extensive disease (>3 quadrants, canal encroachment, multi-level involvement), its overall survival, local recurrence, and distant metastasis did not differ significantly from Group A (hazard ratio [HR] 0.54, p = 0.467; HR 0.46, p = 0.307; HR 0.46, p = 0.237, respectively). Complication rates were comparable between groups A and B.</div></div><div><h3>Conclusion</h3><div>En bloc resection with intentional tumor transgression offers oncologic outcomes comparable to margin-negative en bloc resection in selected patients with more extensive tumors. This technique may be a viable alternative when Enneking-appropriate en bloc resection is not feasible.</div></div>","PeriodicalId":48806,"journal":{"name":"Journal of Bone Oncology","volume":"57 ","pages":"Article 100747"},"PeriodicalIF":3.5000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212137426000096","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Primary spinal sarcoma is rare and technically challenging, particularly when attempting en bloc resection with negative margins. Intentional tumor transgression may be used when Enneking-appropriate en bloc resection is not feasible, but its oncologic implications remain unclear. This study evaluated the feasibility and outcomes of en bloc resection with intentional tumor transgression compared with other resection strategies.
Methods
This multicenter retrospective study included patients who underwent surgery for primary spinal sarcoma across five tertiary hospitals from 2000 to 2022. Patients were grouped by resection method: (A) en bloc resection with negative margins, (B) en bloc resection with intentional tumor transgression, (C) piecemeal resection, and (D) subtotal resection. Tumor extent was assessed using a modified Weinstein-Boriani-Biagini classification. The primary outcome was overall survival; secondary outcomes included local recurrence, distant metastasis, and perioperative complications.
Results
The study included 119 patients (mean age 46.0 ± 19.8 years). Oncological outcomes (overall survival, local recurrence, and distant metastasis) demonstrated significant trends in survival analysis across groups A to D. Although Group B had more extensive disease (>3 quadrants, canal encroachment, multi-level involvement), its overall survival, local recurrence, and distant metastasis did not differ significantly from Group A (hazard ratio [HR] 0.54, p = 0.467; HR 0.46, p = 0.307; HR 0.46, p = 0.237, respectively). Complication rates were comparable between groups A and B.
Conclusion
En bloc resection with intentional tumor transgression offers oncologic outcomes comparable to margin-negative en bloc resection in selected patients with more extensive tumors. This technique may be a viable alternative when Enneking-appropriate en bloc resection is not feasible.
期刊介绍:
The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.
As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.
The areas covered by the journal include:
Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
Preclinical models of metastasis
Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)
Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)
Bone imaging (clinical and animal, skeletal interventional radiology)
Bone biomarkers (clinical and translational applications)
Radiotherapy and radio-isotopes
Skeletal complications
Bone pain (mechanisms and management)
Orthopaedic cancer surgery
Primary bone tumours
Clinical guidelines
Multidisciplinary care
Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.